OrthoPediatrics Corp. KIDS

Competitive advantage analysis · healthcare

Medical Devices & Diagnostics
Overall moat score
68/100
Moderate

About OrthoPediatrics Corp.

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products. Its products comprise PediLoc, PediPlates, … Full KIDS analysis →

Competitive advantage assessment

Key strengths

  • Stable Gross Margin Profile Gross margin stability is strong (score 0.88). Low volatility confirms durable consumable pricing.
  • Durable Capital Returns ROIC durability is strong (score 0.99). Consistent returns confirm the moat is not eroding.

Key risks

  • Operating Margin Compression Operating margin trend is negative (score 0.38). Sustained compression would reduce the commercial moat.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Strong
80

Where KIDS ranks in Medical Devices

OrthoPediatrics Corp. ranks #29 of 160 scored companies in Medical Devices by moat score — the top 18%. The widest moat in the group is iRadimed Corporation (IRMD) at 83/100.

Moat scores for companies ranked near KIDS in Medical Devices
# Company Moat score Rating
25 Bioventus Inc. BVS 69/100 Moderate
26 Artivion, Inc. AORT 68/100 Moderate
27 Bio-Rad Laboratories, Inc. BIO-B 68/100 Moderate
28 Bio-Rad Laboratories, Inc. BIO 68/100 Moderate
29 OrthoPediatrics Corp. KIDS 68/100 Moderate
30 TriSalus Life Sciences, Inc. TLSIW 66/100 Moderate
31 TriSalus Life Sciences, Inc. TLSI 66/100 Moderate
32 AxoGen, Inc. AXGN 66/100 Moderate
33 CONMED Corporation CNMD 65/100 Moderate

See every Medical Devices & Diagnostics company ranked by moat score →

How KIDS scores on the Medical Devices & Diagnostics defenses

Pricing Power & Consumable Moat

Score 80 · 25% of the moat score

In MedTech, pricing power is rarely about the machine — it is about what the machine consumes.

R&D Pipeline & Capital Returns

Score 78 · 20% of the moat score

Research spending is how a device company keeps its installed base current, but spending alone proves nothing.

FCF Quality & Cash Conversion

Score 63 · 20% of the moat score

MedTech companies grow by acquisition, and the resulting intangible amortisation depresses reported earnings without consuming any cash.

Commercial Execution

Score 52 · 15% of the moat score

Devices are sold into hospitals and labs through committees, tenders and long qualification cycles, which makes the sales organisation expensive and hard to replicate.

Capital Structure & Resilience

Score 55 · 12% of the moat score

Serial acquirers carry debt, and the question is whether the cash flows underneath it are dependable enough to service it through a downturn.

Growth Durability

Score 60 · 8% of the moat score

Growth durability separates an expanding installed base from a good product cycle.

How each Medical Devices & Diagnostics defense is measured, in full →

Understanding KIDS's moat

What is OrthoPediatrics Corp.'s moat score?

OrthoPediatrics Corp. (KIDS) scores 68 out of 100 on the StatsAlpha Moat Map, which rates its competitive advantage as moderate. It ranks #29 of 160 scored companies in Medical Devices, the top 18%. The score is a weighted composite of 6 competitive defenses, each measured against industry peers of 159 companies in Medical Devices. Its strongest defense is Pricing Power & Consumable Moat (80/100) and its weakest is Commercial Execution (52/100).

How does OrthoPediatrics Corp. compare with other Medical Devices companies?

OrthoPediatrics Corp. ranks #29 of 160 scored companies in Medical Devices by moat score. The widest moat in Medical Devices is iRadimed Corporation (IRMD) at 83/100. The companies ranked closest are Bio-Rad Laboratories, Inc. (BIO) at 68 just above it and TriSalus Life Sciences, Inc. (TLSIW) at 66 just below it.

How is the moat score calculated?

Each company is scored with an industry-specific template — Medical Devices & Diagnostics in this case, chosen because the defenses that matter to a bank are not the ones that matter to a software company. Every defense combines several financial signals, and each signal is measured as a percentile against a peer group of 159 companies in Medical Devices. The defenses are then weighted to produce the overall score out of 100.

Why is OrthoPediatrics Corp. scored with the Medical Devices & Diagnostics template?

Medical device and diagnostics companies place an instrument once and then sell the consumables, reagents and service that instrument needs for the next decade. The economics are a razor-and-blade model wrapped in regulatory approval and clinician habit, so the MedTech template scores the durability of that installed base rather than the size of any single product launch.

Which competitive defenses are measured for OrthoPediatrics Corp.?

The Medical Devices & Diagnostics template measures 6 defenses, and KIDS scores: Pricing Power & Consumable Moat (80), R&D Pipeline & Capital Returns (78), FCF Quality & Cash Conversion (63), Commercial Execution (52), Capital Structure & Resilience (55), Growth Durability (60). Each is scored independently as a percentile against peers, so a company can be strong on one and weak on another — the overall score reflects how those defenses are weighted for this industry.

Send Feedback
Please select a category.
0/1000